Inflammation, Haemostatic Disturbance, and Obesity: Possible Link to Pathogenesis of Diabetic Retinopathy in Type 2 Diabetes
Table 3
Differences in C-reactive protein, fibrinogen, , total cholesterol, and triglycerides in type 2 diabetic patients divided into three groups according to the diabetic retinopathy status and the level of obesity defined by BMI, WC, and WHR.
CRP
Fibrinogen
Total cholest.
Triglycerides
df
BMI 3 groups
1
0.660
0.4184
0.003
0.9588
2.877
0.0930
6.734
0.0109
6.353
0.0133
DR
1
1.711
0.1939
0.157
0.6927
4.776
0.0312
1.132
0.2899
0.986
0.3231
BMI 3 gr. * DR
3
0.335
0.7997
0.878
0.4552
1.231
0.3025
0.938
0.4254
2.197
0.0932
WC 3 groups
1
5.077
0.0265
1.287
0.2593
0.763
0.3846
0.010
0.9217
0.676
0.4130
DR
1
2.395
0.1249
0.662
0.4180
3.479
0.0651
0.268
0.6057
0.891
0.3476
WC 3 gr. * DR
3
0.320
0.8108
1.971
0.1233
0.142
0.9345
0.533
0.6604
1.063
0.3686
WHR 3 groups
2
2.536
0.0844
4.809
0.0102
0.790
0.4566
1.666
0.1943
1.697
0.1885
DR
2
2.163
0.1204
1.198
0.3063
2.875
0.0612
0.658
0.5200
1.795
0.1716
WHR 3 gr. * DR
4
1.639
0.1704
1.061
0.3799
1.769
0.1411
0.341
0.8499
1.009
0.4065
DR: diabetic retinopathy; BMI: body mass index (kg/m²); WC: waist circumference (cm); WHR: waist-to-hip ratio; CRP: C-reactive protein; : glycated hemoglobin value obtained by statistical analysis of data from the National Registry for Diabetes (CroDiabNet).
